Kros JM - Search Results

1

[Favourable result for temozolomide in recurrent high-grade glioma].

Taal W, van der Rijt CD, Sillevis Smitt PA, Kros JM, van Heuvel I, Enting RH, van den Bent MJ. Taal W, et al. Among authors: kros jm. Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1393-9. Ned Tijdschr Geneeskd. 2005. PMID: 15997692 Dutch.

2

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

Straathof CS, van den Bent MJ, Ma J, Schmitz PI, Kros JM, Stoter G, Vecht CJ, Schellens JH. Straathof CS, et al. Among authors: kros jm. J Neurooncol. 1998 Mar;37(1):1-8. doi: 10.1023/a:1005835212246. J Neurooncol. 1998. PMID: 9525832

3

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HG, Taphoorn MJ, Zonnenberg BA, Tijssen CC, Twijnstra A, Punt CJ, Boogerd W. van den Bent MJ, et al. Among authors: kros jm. Neurology. 1998 Oct;51(4):1140-5. doi: 10.1212/wnl.51.4.1140. Neurology. 1998. PMID: 9781544

4

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

van den Bent MJ, Schellens JH, Vecht CJ, Sillevis Smit PA, Loosveld OJ, Ma J, Tijssen CC, Jansen RL, Kros JM, Verweij J. van den Bent MJ, et al. Among authors: kros jm. Eur J Cancer. 1998 Sep;34(10):1570-4. doi: 10.1016/s0959-8049(98)00138-5. Eur J Cancer. 1998. PMID: 9893630 Clinical Trial.

5

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates.

Driesse MJ, Vincent AJ, Sillevis Smitt PA, Kros JM, Hoogerbrugge PM, Avezaat CJ, Valerio D, Bout A. Driesse MJ, et al. Among authors: kros jm. Gene Ther. 1998 Aug;5(8):1122-9. doi: 10.1038/sj.gt.3300695. Gene Ther. 1998. PMID: 10326036

6

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.

Luider TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Luider TM, et al. Among authors: kros jm. Electrophoresis. 1999 Apr-May;20(4-5):1087-91. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1087::AID-ELPS1087>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10344289

7

Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH).

Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van Dekken H. Kros JM, et al. J Pathol. 1999 Jul;188(3):282-8. doi: 10.1002/(SICI)1096-9896(199907)188:3<282::AID-PATH355>3.0.CO;2-S. J Pathol. 1999. PMID: 10419597

8

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity.

Driesse MJ, Esandi MC, Kros JM, Avezaat CJ, Vecht C, Zurcher C, van der Velde I, Valerio D, Bout A, Sillevis Smitt PA. Driesse MJ, et al. Among authors: kros jm. Gene Ther. 2000 Aug;7(16):1401-9. doi: 10.1038/sj.gt.3301250. Gene Ther. 2000. PMID: 10981667

9

Temozolomide chemotherapy in recurrent oligodendroglioma.

van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF. van den Bent MJ, et al. Among authors: kros jm. Neurology. 2001 Jul 24;57(2):340-2. doi: 10.1212/wnl.57.2.340. Neurology. 2001. PMID: 11468326

10

['Benign' meningioma].

Wolbers JG, Avezaat CJ, Nowak PJ, Kros JM. Wolbers JG, et al. Among authors: kros jm. Ned Tijdschr Geneeskd. 2001 Nov 10;145(45):2153-7. Ned Tijdschr Geneeskd. 2001. PMID: 11727610 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters